c Streptococcus suis serotype 2 is an emerging zoonotic pathogen and causes severe disease in both pigs and human beings. Cefquinome (CEQ), a fourth-generation cephalosporin, exhibits broad-spectrum activity against Gram-positive bacteria such as S. suis. This study evaluated the in vitro and in vivo antimicrobial activities of CEQ against four strains of S. suis serotype 2 in a murine neutropenic thigh infection model. We investigated the effect of varied inoculum sizes (10 6 to 10 8 CFU/thigh) on the pharmacokinetic (PK)/pharmacodynamic (PD) indices and magnitudes of a particular PK/PD index or dose required for efficacy. Dose fractionation studies included total CEQ doses ranging from 0.625 to 640 mg/kg/24 h. Data were analyzed via a maximum effect (E max ) model using nonlinear regression. The PK/PD studies demonstrated that the percentage of time that serum drug levels were above the MIC of free drug (%ƒT >MIC ) in a 24-h dosing interval was the primary index driving the efficacy of both inoculum sizes (R 2 ؍ 91% and R 2 ؍ 63%). CEQ doses of 2.5 and 40 mg/kg body weight produced prolonged postantibiotic effects (PAEs) of 2.45 to 8.55 h. Inoculum sizes had a significant influence on CEQ efficacy. Compared to the CEQ exposure and dosages in tests using standard inocula, a 4-fold dose (P ؍ 0.006) and a 2-fold exposure time (P ؍ 0.01) were required for a 1-log kill using large inocula of 10 8 CFU/thigh.
Streptococcus suis is an important pathogen in the swine industry and causes significant economic losses worldwide. Moreover, it is an emerging zoonotic pathogen causing severe infection in people who have close contact with diseased pigs or pork-derived products (1, 2). To date, 35 serotypes based on S. suis capsular antigens have been described. S. suis serotype 2 is the most virulent and the dominant pathogenic serotype. It has been associated with a variety of severe clinical infections such as meningitis, septicemia, pneumonia, arthritis, and endocarditis in both pigs and humans (3, 4). Significant public health concerns were raised due to large outbreaks of S. suis 2 in humans that occurred in China in 1998 and 2005 that caused high morbidity and mortality (5). Because suitable vaccines were not available, the control of S. suis 2 infections depended almost entirely on the use of antimicrobials. However, the occurrence of high levels of resistance of S. suis to certain antimicrobials (e.g., macrolides, lincosamides, tetracyclines, and sulfonamides) has limited the choice of antimicrobial agents for treatment (6). It has previously been reported that the majority of S. suis strains are susceptible to -lactams (MIC of Յ0.03 g/ml). This suggested that these drugs may be efficacious in the treatment of S. suis 2 infections (7).Cefquinome (CEQ) is a fourth-generation cephalosporin developed solely for veterinary use and has been highly effective against a wide variety of Gram-positive and Gram-negative bacteria (8). CEQ has also been tested and was shown to be effective in animals using a standard thig...
In this study, a specific and sensitive LC-MS/MS method for the simultaneous analysis of type-B trichothecenes (deoxynivalenol, 3-acetyldeoxynivalenol, and 15-acetyldeoxynivalenol) and the de-epoxy metabolite of deoxynivalenol (de-epoxy-deoxynivalenol) in chicken muscle, liver, kidney, and fat tissues was developed and validated. The method involved an extraction step using ethyl acetate, followed by the evaporation of the supernatant, which was further purified by an Oasis HLB SPE cartridge (Waters, Milford, MA, USA). Chromatographic separation was performed on a C 18 column by detection with MS in multiple-reaction monitoring mode and using a gradient elution program with 0.1% formic acid in water and methanol. The correlation coefficients (r) for each calibration curve were >0.99 within the experimental concentration range. The extraction recoveries ranged from 73.7 to 106.4%, with intraday and interday RSD < 11.6% at three levels of concentrations of 2, 10, and 100 g/kg. The decision limits and the detection capabilities of the analytes in the chicken tissues ranged from 0.16 to 0.92 and 0.68 to 2.07 g/kg, respectively. The results demonstrated the applicability of this sensitive procedure to the determination of trichothecenes in chicken tissue samples.
A rapid, sensitive, and specific high-performance liquid chromatography tandem mass spectrometric method was developed for the simultaneous determination and confirmation of amoxicillin and clavulanic acid in plasma. Plasma sample was subjected to a simple deproteinization with acetonitrile, and then the supernatant was directly diluted by water. Analysis was performed on a Phenomenex Luna C 8 reversed-phase column by detection with mass spectrometry in negative ions multiple reaction monitoring mode. A gradient elution program with 0.1% formic acid and acetonitrile was performed at a flow of 0.25 mL min À1 . There is good linearity in the range of 0.5-500 ng mL À1 for both amoxicillin and clavulanic acid. The decision limits of amoxicillin and clavulanic acid were 0.06 ng mL À1 and 0.08 ng mL À1 in plasma, respectively, and the detection capabilities of two analytes were below 0.5 ng mL À1 . Acceptable precision and accuracy were obtained for concentrations over the standard curve range. The extraction recoveries of amoxicillin and clavulanic acid were between 102% and 115% in plasma at three spiked levels of 0.5, 50, and 500 ng mL À1 , with the relative standard deviations less than 15% for each analyte. The developed method was applied to pharmacokinetic studies of amoxicillin and clavulanic acid tablets in healthy beagles.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.